Picton Mahoney Asset Management Bio Rad Laboratories, Inc. Transaction History
Picton Mahoney Asset Management
- $5.81 Billion
- Q1 2025
A detailed history of Picton Mahoney Asset Management transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Picton Mahoney Asset Management holds 72 shares of BIO stock, worth $16,338. This represents 0.0% of its overall portfolio holdings.
Number of Shares
72
Previous 98
26.53%
Holding current value
$16,338
Previous $32,000
43.75%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BIO
# of Institutions
462Shares Held
18.9MCall Options Held
12.7KPut Options Held
14.4K-
Vanguard Group Inc Valley Forge, PA1.91MShares$434 Million0.01% of portfolio
-
First Eagle Investment Management, LLC1.57MShares$355 Million0.8% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$352 Million0.01% of portfolio
-
Veritas Asset Management LLP913KShares$207 Million2.52% of portfolio
-
Dimensional Fund Advisors LP Austin, TX877KShares$199 Million0.05% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $5.59B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...